Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost-utility analysis.
Zixuan ZhaoChi ChenXueshan SunDuo ZhouXinwen HuangHengjin DongPublished in: Journal of medical screening (2021)
NBS using MS/MS can be considered cost-effective in China. The nationwide promotion of NBS using MS/MS deserves priority consideration and sufficient publicity.